Regentis Biomaterials Ltd. (RGNT) stock
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$0.84−0.30 (-26.34%)
Close on Nov 19, 2026Market cap $4.35MP/E –Yield –
Regentis Biomaterials revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Regentis Biomaterials
Regentis Biomaterials has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?